These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1269 related items for PubMed ID: 25409678
1. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial. Bruyère R, Soudry-Faure A, Capellier G, Binquet C, Nadji A, Torner S, Blasco G, Yannaraki M, Barbar SD, Quenot JP. Trials; 2014 Nov 19; 15():449. PubMed ID: 25409678 [Abstract] [Full Text] [Related]
2. Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial. Quenot JP, Helms J, Bourredjem A, Dargent A, Meziani F, Badie J, Blasco G, Piton G, Capellier G, Mezher C, Rebibou JM, Nadji A, Crepin T, Barbar SD, Fleck C, Cransac A, Boulin M, Binquet C, Soudry-Faure A, Bruyère R, VERROU-REA Trial Investigators and the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). Ann Intensive Care; 2019 Jul 01; 9(1):75. PubMed ID: 31264073 [Abstract] [Full Text] [Related]
3. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Winnicki W, Herkner H, Lorenz M, Handisurya A, Kikić Ž, Bielesz B, Schairer B, Reiter T, Eskandary F, Sunder-Plassmann G, Sengoelge G. Kidney Int; 2018 Mar 01; 93(3):753-760. PubMed ID: 28890326 [Abstract] [Full Text] [Related]
4. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial. Bonkain F, Van Hulle F, Janssens P, Catalano C, Allamani M, Stolear JC, Vandervelde D, Libertalis M, Treille S, Couttenye MM, Dhondt A, Van Biesen W, Fils JF, Tielemans C, Wissing KM. J Vasc Access; 2017 Sep 11; 18(5):436-442. PubMed ID: 28623638 [Abstract] [Full Text] [Related]
5. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study. Vercaigne LM, Allan DR, Armstrong SW, Zacharias JM, Miller LM. J Vasc Access; 2016 Sep 11; 17(1):55-62. PubMed ID: 26660041 [Abstract] [Full Text] [Related]
6. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients. Thomson PC, Morris ST, Mactier RA. Clin Nephrol; 2011 Mar 11; 75(3):212-7. PubMed ID: 21329631 [Abstract] [Full Text] [Related]
7. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial). Correa Barcellos F, Pereira Nunes B, Jorge Valle L, Lopes T, Orlando B, Scherer C, Nunes M, Araújo Duarte G, Böhlke M. Infection; 2017 Apr 11; 45(2):139-145. PubMed ID: 27573387 [Abstract] [Full Text] [Related]
8. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN. Moran JE, Ash SR, ASDIN Clinical Practice Committee. Semin Dial; 2008 Apr 11; 21(5):490-2. PubMed ID: 18764795 [Abstract] [Full Text] [Related]
10. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, Zervos MJ, Adams E, Yee J. Clin J Am Soc Nephrol; 2014 Jul 11; 9(7):1232-9. PubMed ID: 24970874 [Abstract] [Full Text] [Related]
11. Non-tunneled versus tunneled dialysis catheters for acute kidney injury requiring renal replacement therapy: a prospective cohort study. Mendu ML, May MF, Kaze AD, Graham DA, Cui S, Chen ME, Shin N, Aizer AA, Waikar SS. BMC Nephrol; 2017 Dec 04; 18(1):351. PubMed ID: 29202728 [Abstract] [Full Text] [Related]
13. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial. Kanaa M, Wright MJ, Akbani H, Laboi P, Bhandari S, Sandoe JA. Am J Kidney Dis; 2015 Dec 04; 66(6):1015-23. PubMed ID: 26141306 [Abstract] [Full Text] [Related]
14. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study. Van Hulle F, Bonkain F, De Clerck D, Aerden D, Vanwijn I, Tielemans C, Wissing KM. J Vasc Access; 2019 Jan 04; 20(1):60-69. PubMed ID: 29893163 [Abstract] [Full Text] [Related]
15. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials. Mai H, Zhao Y, Salerno S, Li Y, Feng Y, Ma L, Fu P. Int Urol Nephrol; 2019 Jun 04; 51(6):1019-1033. PubMed ID: 31012037 [Abstract] [Full Text] [Related]
16. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D. Am J Kidney Dis; 2009 Jun 04; 53(6):1034-41. PubMed ID: 19394731 [Abstract] [Full Text] [Related]
17. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT). Gudiol C, Nicolae S, Royo-Cebrecos C, Aguilar-Guisado M, Montero I, Martín-Gandul C, Perayre M, Berbel D, Encuentra M, Arnan M, Cisneros-Herreros JM, Carratalà J. Trials; 2018 May 02; 19(1):264. PubMed ID: 29720244 [Abstract] [Full Text] [Related]
19. Efficacy and safety of peripherally inserted central venous catheters in acute cardiac care management. Poletti F, Coccino C, Monolo D, Crespi P, Ciccioli G, Cordio G, Seveso G, De Servi S. J Vasc Access; 2018 Sep 02; 19(5):455-460. PubMed ID: 29514546 [Abstract] [Full Text] [Related]
20. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ, CITRATE Study Group. J Am Soc Nephrol; 2005 Sep 02; 16(9):2769-77. PubMed ID: 16033861 [Abstract] [Full Text] [Related] Page: [Next] [New Search]